JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
31 hedge funds and large institutions have $18.2M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $51K
Holders
31
Holding in Top 10
–
Calls
–
Puts
$51K
Top Buyers
| 1 | +$378K | |
| 2 | +$223K | |
| 3 | +$129K | |
| 4 |
AG
Algert Global
San Francisco,
California
|
+$112K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$79K |
Top Sellers
| 1 | -$505K | |
| 2 | -$110K | |
| 3 | -$109K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$84.5K |
| 5 |
SIM
Spark Investment Management
New York
|
-$64.5K |